Showing results (681-690 of 1,487) with videos related to
Sort By:
Pageof 149
Archives of Neurology|November 1, 1990
Quantitative electroencephalographic correlates of cognitive decline in normal elderly subjectsP C Williamson, H Merskey, S Morrison, et al.American Journal of Clinical Oncology|May 13, 2009
Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicityAshesh B Jani, Timothy H Fox, Deborah Blaustein, et al.BMC Cancer|January 15, 2003
Growth-inhibitory effects of the chemopreventive agent indole-3-carbinol are increased in combination with the polyamine putrescine in the SW480 colon tumour cell lineE Ann Hudson, Lynne M Howells, Barbara Gallacher-Horley, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 4, 2016
Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and DystoniaRenato P Munhoz, Marina Picillo, Susan H Fox, et al.The Journal of Rheumatology|February 1, 1988
The arthropathy of Wilson's disease: clinical and pathologic featuresK A Menerey, W Eider, G J Brewer, et al.Human Reproduction (Oxford, England)|September 13, 2012
The association between severe obesity and characteristics of failed fertilized oocytesRonit Machtinger, Catherine M H Combelles, Stacey A Missmer, et al.Journal of Pediatric Orthopedics. Part B|August 27, 2013
Treatment of congenital clubfoot with the Ponseti method: the parents' perspectiveMonica P Nogueira, Mariana Farcetta, Mark H Fox, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 23, 2010
Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's diseaseSusan H Fox, Naomi Visanji, Gaby Reyes, et al.International Journal of Psychiatry in Medicine|July 16, 2008
Assessing the prevalence of depression among individuals with diabetes in a Medicaid managed-care programLinda S Kahn, Chester H Fox, Roger S McIntyre, et al.The Lancet. Neurology|March 16, 2020
Initiation of pharmacological therapy in Parkinson's disease: when, why, and howRob M A de Bie, Carl E Clarke, Alberto J Espay, et al.Pageof 149